NEW YORK (TheStreet.com) -- CHANGE IN RATINGS

Alkermes (ALKS) - Get Report downgraded at Jefferies from Buy to Hold. $11.50 price target. JNJ is pulling away from the company's 4-week risperidone formulation.

Alpha Natural Resources

(ANR)

reinstated at Barclays with an Overweight rating and $50 price target. Analysts said high-quality coal assets combined with the stability and scale of Foundation's thermal coal production makes a compelling investment opportunity. 2009 EPS estimate cut from $2.10 to $1.75 and 2010 raised from $2.90 to $3.20.

Bed, Bath & Beyond

(BBBY) - Get Report

rated new Buy at Citigroup. $44 price target. Valuation is correlated to square footage growth.

Dollar Tree

(DLTR) - Get Report

upgraded at Barclays from Equal Weight to Overweight on larger customer base and EPS benefits from cost cutting. 2010 and 2011 EPS estimates raised to $3.36 from $3.00 and to $4.10 from $3.46, respectively. Price target lifted to $64 from $48.

Greenhill

(GHL) - Get Report

upgraded at Goldman to Neutral from Sell and increased the price target to $75 from $65. Analysts said M&A potentially improving and Greenhill stands to benefit from this trend more than peers. 2010 and 2011 EPS estimates increased to $3.20 from $3.00 and to $4.00 from $3.40.

Heartland Express

(HTLD) - Get Report

upgraded at UBS. Rating raised to Neutral from Sell. Price target raised to $16 from $14. Maintains 2009 EPS estimates of $0.68.

Knight Transportation

(KNX) - Get Report

upgraded at UBS. Rating raised to Neutral from Sell. Price target raised to $17.00 from $15.50. Maintains 2009 EPS estimates of $0.61.

Olin Corp

(OLN) - Get Report

upgraded at Barclays to Overweight from Equal Weight on belief that the bottom of the cl-alkali cycle has been reached. 2009 EPS estimate raised to $0.83 from $0.52 and 2010 set at $0.51. Price target surged from $11 to $22.

Whiting Petroleum

(WLL) - Get Report

upgraded at Credit Suisse to Outperform from Neutral and boosted the price target to $54 from $42. Based on higher growth and lower costs as displayed in 2Q results. 2009 and 2010 EPS estimates raised to -$0.38 from -$0.91 and to $1.36 from $0.66, respectively.

Williams-Sonoma

(WSM) - Get Report

rated new Buy at Citigroup. $21 price target. Company has upside earnings potential, based on expected margin recovery.

STOCK COMMENTS / EPS CHANGES

Apollo Investment

(AINV) - Get Report

price target lifted at Merrill/BofA to $11 from $10. A completed $181mn equity raise strengthens ability to tap attractive opportunities. 2009 EPS estimate drops to $1.35 from $1.39 but 2010 increases to $1.48 from $1.30. Reiterate Buy rating.

Campbell Soup

(CPB) - Get Report

numbers increased at UBS through 2010. Company is cutting costs and currency trends should improve. Neutral rating and new $32 price target.

Dollar Tree

(DLTR) - Get Report

target, estimates increased at Morgan Stanley to $57 from $52 as traffic continues to accelerate. 2010 and 2011 EPS estimates boosted to $3.38 from $3.08 and to $3.80 from $3.46. Maintain Overweight rating.

Endo Pharmaceuticals

(ENDP) - Get Report

estimates upped at Citigroup through 2011. Company to see high in-licensing proceeds from Fortesta. Buy rating and $27 price target.

Evercore Partners

(EVR) - Get Report

target, estimates changed at Goldman to $28 from $22. 2009 EPS estimate lowered to $0.62 from $0.65 and 2010 EPS estimate raised to $1.40 from $1.20. Maintain Neutral rating.

Guess

(GES) - Get Report

estimates, target raised at Credit Suisse. Shares now seen reaching $43. Estimates also increased, based on higher realized sales and margins. Outperform rating.

Guess

(GES) - Get Report

price target lifted at Barclays to $36 from $31 after a well executed 2Q. 2009 and 2010 EPS estimates raised to $2.15 from $1.88 and to $2.40 from $2.20, respectively. Maintain Equal Weight rating.

International Paper

(IP) - Get Report

numbers boosted at Deutsche. Shares now seen reaching $28. Estimates also raised to reflect better containerboard and uncoated paper pricing. Buy rating.

Massey Energy

( MEE) price target lifted at Merrill/BofA to $32 from $25, driven by higher met coal pricing and higher target multiples. 2009 EPS estimate set at $0.90 and 2010 increased $0.20 to $1.70. Maintain Neural rating.

Mead Johnson

(MJN)

target, estimates inflated at Morgan Stanley to $41 from $29 after a solid 2Q displayed a more attractive growth profile. 2009, 2010, and 2011 EPS estimates jumped to $2.25/$2.45/$2.71 from $2.00/$2.19/$2.44. Reiterate Equal Weight rating.

Monsanto

(MON)

2010 EPS estimate lowered at Morgan Stanley from $4.40 to $4.10. Maintain 2009 and 2011 EPS estimate of $4.40 and $5.25, respectively. Reiterate Overweight rating and $104 price target.

This article was written by a staff member of TheStreet.com.